Acalabrutinib maleate is the maleate salt form of acalabrutinib, an orally available inhibitor of Bruton's tyrosine kinase (BTK). It is a pharmaceutical raw material used in the manufacturing of compounds that target B-cell receptor signaling pathways for research purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Acalabrutinib maleate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Calquence
pharmaceutical raw material
Acalabrutinib
pharmaceutical raw material
Pirtobrutinib
pharmaceutical raw material
Ginsenoside Rg1
pharmaceutical raw material
Acoramidis hydrochloride
pharmaceutical raw material
Retapamulin
pharmaceutical raw material
Calcium orotate
pharmaceutical raw material
Acalabrutinib D4
pharmaceutical raw material
4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide;(Z)-but-2-enedioic acid
JWEQLWMZHJSMEC-AFJTUFCWSA-N
CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5.C(=C\C(=O)O)\C(=O)O
Sourcing Acalabrutinib maleate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.